Valuation: Marksans Pharma Limited

Capitalization 12TCr 134.48Cr 115.02Cr 107.24Cr 100Cr 184.14Cr 204.81Cr 1.29TCr 490.45Cr 5.4TCr 504.31Cr 493.94Cr 20TCr P/E ratio 2025
26.5x
P/E ratio 2026 * 23.7x
Enterprise value 12TCr 134.48Cr 115.02Cr 107.24Cr 100Cr 184.14Cr 204.81Cr 1.29TCr 490.45Cr 5.4TCr 504.31Cr 493.94Cr 20TCr EV / Sales 2025
3.84x
EV / Sales 2026 * 3.66x
Free-Float
53.65%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.86%
1 week-3.23%
Current month-2.66%
1 month-2.08%
3 months+23.82%
6 months-2.28%
Current year-14.19%
More quotes
1 week 249.5
Extreme 249.5
266.6
1 month 235.9
Extreme 235.9
266.6
Current year 171
Extreme 171
306.9
1 year 171
Extreme 171
358.7
3 years 45.4
Extreme 45.4
358.7
5 years 34.35
Extreme 34.35
358.7
10 years 9.85
Extreme 9.85
358.7
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 06/10/2005
Director of Finance/CFO 56 06/09/2002
Compliance Officer - -
Director TitleAgeSince
Chairman 53 06/10/2015
Director/Board Member 53 25/09/2014
Director/Board Member 71 11/07/2019
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.86%-3.23%+34.57%+422.69% 134.44Cr
+0.30%+1.58%-16.38%+145.07% 71TCr
-0.50%+0.57%+4.68%-10.78% 38TCr
-1.31%+1.67%+13.02%+26.23% 34TCr
-3.64%-2.74%-55.22%+8.38% 31TCr
-2.36%-1.23%+0.78%-21.80% 26TCr
-3.00%-1.93%-3.83%+16.05% 24TCr
-1.66%+1.10%-14.76%-6.40% 22TCr
-0.79%+3.00%-34.75%-10.94% 21TCr
-1.70%-1.00%-10.75%+19.56% 16TCr
Average -1.55%+0.39%-8.26%+58.81% 28.18TCr
Weighted average by Cap. -1.30%+0.64%-12.49%+38.61%
See all sector performances

Financials

2025 2026 *
Net sales 2.62TCr 30Cr 26Cr 24Cr 23Cr 42Cr 46Cr 292.04Cr 111.2Cr 1.22TCr 114.34Cr 111.99Cr 4.5TCr 3.15TCr 37Cr 31Cr 29Cr 27Cr 50Cr 56Cr 351.54Cr 133.86Cr 1.47TCr 137.64Cr 134.81Cr 5.41TCr
Net income 388.3Cr 4.53Cr 3.87Cr 3.61Cr 3.35Cr 6.2Cr 6.89Cr 43Cr 17Cr 181.65Cr 17Cr 17Cr 667.53Cr 486.65Cr 5.67Cr 4.85Cr 4.52Cr 4.2Cr 7.77Cr 8.64Cr 54Cr 21Cr 227.66Cr 21Cr 21Cr 836.6Cr
Net Debt - -
More financial data * Estimated data
Logo Marksans Pharma Limited
Marksans Pharma Limited is an India-based company, which is engaged in research, manufacturing and marketing of generic pharmaceutical formulations in the global markets. The Company's product portfolio spreads various therapeutic segments of cardiovascular system (CVS), central nervous system (CNS), antidiabetic, pain management, cough and cold, gastroenterological, and anti-allergies. Its product portfolio includes tablets (plain, enteric-coated and film-coated), hard capsules, soft gelatin capsules, oral liquids and ointments. Its consumer self-care products (over the counter) include pain management, upper respiratory, digestive health, vitamins minerals and supplements (VMS) and skin care products. The Company's prescription - Rx therapeutic segments include CVS, CNS, oncology, anti-diabetics and anti-biotic. Its end consumers include retail chains, pharmacy stores, hospitals and institutions. It has manufacturing facilities in India, the United Kingdom and the United States.
Employees
1,141
More about the company
Date Price Change Volume
11/25/11 254.55 -0.86% 12,43,743
10/25/10 256.75 -0.81% 4,65,844
09/25/09 258.85 +2.54% 10,79,028
08/25/08 252.45 -1.92% 9,98,015
07/25/07 257.40 -2.15% 8,96,682

Delayed Quote NSE India S.E., July 11, 2025 at 05:19 pm IST

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
254.55INR
Average target price
301.00INR
Spread / Average Target
+18.25%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. MARKSANS Stock